Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy (Q40278001)

19 September 2017

title

Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy (English)

1 reference

19 September 2017

0 references

1 reference

1 reference

Liu Y

1 reference

19 September 2017

Deisseroth A

series ordinal

1 reference

19 September 2017

publication date

5 May 2006

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

19 September 2017

page(s)

845-855

1 reference

19 September 2017

cites work

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700962

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700962

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700962

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700962

Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700962

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700962

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700962

Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700962

A simplified system for generating recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700962

A novel attenuated replication-competent adenovirus for melanoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700962

Engineering conditionally replication-competent adenoviral vectors carrying the cytosine deaminase gene increases the infectivity and therapeutic effect for breast cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700962

E1A as a tumor suppressor gene: commentary re S. Madhusudan et al. A multicenter Phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HE

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700962

Adenovirus E1A under the control of heterologous promoters: wide variation in E1A expression levels has little effect on virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700962

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700962

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700962

1 reference

Dimensions Publication ID

19 September 2017

1047256798

0 references

1 reference